Atlas Trials

KRAS Positive Patients With Non-small Cell Lung Cancer

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch KRAS Positive Patients With Non-small Cell Lung Cancer

RecordFirmDate
A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer (NCT02283320)BIND Therapeutics2014-09-01

Track KRAS Positive Patients With Non-small Cell Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.